Eén van de langst durende debatten in marketing- en saleskringen: wat is beter, short copy of long copy? De short-fans prediken short copy omdat mensen tegenwoordig weinig lezen en er dus geen reden is om long-form copy...
Latest articles
Researchers warn about gangrene cases in patients on SGLT2 diabetes drugs
As SGLT2 drugmakers count on the blockbuster diabetes drugs for growth, a team of researchers has tracked dozens of cases of Fournier’s gangrene, a flesh-eating bacterial infection in the genitals, among patients...
AstraZeneca announces positive results from roxadustat global phase III trials to treat anaemia in patients with CKD
AstraZeneca announced top─line results from the pooled cardiovascular (CV) safety analyses of the global phase III programme for roxadustat, a first─in─class hypoxia─inducible─factor prolyl hydroxylase inhibitor
Novartis phase III EXPAND study shows treatment with Mayzent has clinically meaningful positive impact on CPS in patients with SPMS
Novartis announced a new analysis of the phase III EXPAND study, demonstrating that treatment with Mayzent (siponimod) had a clinically meaningful positive impact on cognitive processing speed (CPS) in patients with...
Groen licht voor drie middelen
De Committee for Medicinal Products for Human Use (CHMP) heeft een positief advies gegeven over nieuwe handelsvergunningen voor drie geneesmiddelen. Het oncolyticum lorlatinib (Lorviqua) ontving een voorwaardelijke...
GW Pharma’s Epidiolex scores in rare childhood onset epilepsy Phase 3 trial
GW Pharma’s Epidiolex has shown positive Phase 3 trial results for the fifth time in a row, after meeting primary endpoints in a randomised, double blind, clinical study of patients with Tuberous Sclerosis Complex...
